Suresh S. Ramalingam

Also affiliated with Cancer Institute (WIA), Piedmont Cancer Institute, AstraZeneca (Netherlands), AstraZeneca (Poland), Winship Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

7.8Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Pan-cancer analysis of whole genomes

Nature(2020)10.1038/s41586-020-1969-6

Top 3%

5.9DataRank

Top 3%3307 citations

Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Hiroyuki Aburatani, David J. Adams +1244 more

Papers

Driven by 67 papers — median percentile 89. Top paper: “Pan-cancer analysis of whole genomes”.

Pan-cancer analysis of whole genomes

Nature(2020)10.1038/s41586-020-1969-6

Top 3%

5.9DataRank

Top 3%3307 citations

Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Hiroyuki Aburatani, David J. Adams +1244 more

Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

Cell Reports(2018)10.1016/j.celrep.2018.03.046

N/A

5.5DataRank · unranked

186 citations

Francisco Sanchez-Vega, Konnor C. La, Joshua Armenia, Walid K. Chatila, Augustin Luna +869 more

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial

Nature Medicine(2021)10.1038/s41591-021-01541-0

N/A

3.9DataRank · unranked

137 citations

Valsamo Anagnostou, Zhuoxin Sun, Suzanne E. Dahlberg, Hedy L. Kindler, Noushin Niknafs +22 more

Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer

JAMA Oncology(2021)10.1001/jamaoncol.2021.2209

N/A

3.1DataRank · unranked

105 citations

Mary W. Redman, Lyudmila Bazhenova, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +14 more

A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753)

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.09.013

N/A

2.3DataRank · unranked

79 citations

Mary W. Redman, Susanne M. Arnold, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +12 more

Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001302

N/A

2.2DataRank · unranked

66 citations

Kristin Higgins, Zhengjia Chen, Gabriel Sica, Conor Steuer, Chao Zhang +12 more

Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400F, NCT03373760)

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002973

Top 11%

1.9DataRank

Top 11%47 citations

Mary W. Redman, Naiyer A. Rizvi, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +14 more

Oncogenic Signaling Pathways in The Cancer Genome Atlas

Cell(2018)10.1016/j.cell.2018.03.035

N/A

1.2DataRank · unranked

3322 citations

Marco Mina, Joshua Armenia, Walid K. Chatila, Augustin Luna, Konnor C. La +891 more

PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program

Nature(2022)10.1038/s41586-022-05257-0

N/A

0.868DataRank · unranked

326 citations

Koichi Araki, Maria A. Cardenas, Peng Li, Rohit R. Jadhav, Haydn Kissick +26 more

Patient‐reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial

Cancer Medicine(2020)10.1002/cam4.3416

N/A

0.523DataRank · unranked

9 citations

Fengmin Zhao, Taofeek K. Owonikoko, Josephine Feliciano, Nisha Mohindra, Suzanne E. Dahlberg +10 more

Expression of tdTomato and luciferase in a murine lung cancer alters the growth and immune microenvironment of the tumor

PLoS ONE(2021)10.1371/journal.pone.0254125

N/A

0.470DataRank · unranked

22 citations

Ramireddy Bommireddy, Luis E. Muñoz, Rohini N. Guin, Changyong Wei, Amanda N. Ruggieri +7 more

Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas

UNC Libraries(2020)10.17615/jcyr-9v75

N/A

0.442DataRank · unranked

18 citations

Candace Shelton, Matthew Meyerson, Carrie Cibulskis, Jia Liu, Joshua Armenia +95 more

Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1 -Mutant Lung Cancer

Cancer Research(2024)10.1158/0008-5472.can-23-2631

N/A

0.342DataRank · unranked

5 citations

Chang-Soo Seong, Rebecca E. Parker, Amy Herrera, Bhakti Dwivedi, Robert A. Arthur +10 more

Prognostic significance of an invasive leader cell–derived mutation cluster on chromosome 16q

Cancer(2020)10.1002/cncr.32903

N/A

0.312DataRank · unranked

7 citations

Manali Rupji, Bhakti Dwivedi, Jeanne Kowalski, Jessica Konen, Taofeek K. Owonikoko +4 more

Phase I study of palbociclib with cisplatin or carboplatin in the management of patients with advanced pancreatic cancer

The Oncologist(2025)10.1093/oncolo/oyaf284

N/A

0.165DataRank · unranked

2 citations

R. Donald Harvey, Christina Wu, Elise Hitron, Hannah Collins, Suzanne Scott +7 more

Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2020.12.017

N/A

0DataRank · unranked

28 citations

Opeyemi A. Jegede, Suzanne E. Dahlberg, Heather A. Wakelee, Steven M. Keller, William Tester +7 more

Membrane-Associated RING-CH 8 Functions as a Novel PD-L1 E3 Ligase to Mediate PD-L1 Degradation Induced by EGFR Inhibitors

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-21-0147

N/A

0DataRank · unranked

43 citations

Jianping Guo, Karin A. Vallega, C. Hu, Zhen Chen, Yunfu Deng +7 more

Discovery of Small Molecule Bak Activator for Lung Cancer Therapy

Theranostics(2021)10.7150/thno.60349

N/A

0DataRank · unranked

34 citations

Abu Syed Md Anisuzzaman, Andrew T. Magis, Guo Chen, Maohua Xie, Guojing Zhang +6 more

Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair–Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G

Clinical Lung Cancer(2021)10.1016/j.cllc.2021.01.001

N/A

0DataRank · unranked

32 citations

Mary W. Redman, Lauren A. Byers, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +12 more

Surgical Outcomes for Early Stage Non-small Cell Lung Cancer at Facilities With Stereotactic Body Radiation Therapy Programs

CHEST Journal(2021)10.1016/j.chest.2021.11.004

N/A

0DataRank · unranked

15 citations

William A. Stokes, Manali Rupji, Yuan Liu, Onkar V. Khullar, Nikhil Sebastian +9 more

A Review of Immunotherapy for Stage III and Metastatic Non-Small Cell Lung Cancer and the Rationale for the ECOG-ACRIN EA5181 Study

The Oncologist(2021)10.1002/onco.13725

N/A

0DataRank · unranked

5 citations

Zhuoxin Sun, Bonnie Ky, Jenica Upshaw, Sharyn I. Katz, Thomas J. FitzGerald +10 more

The CD8 + T cell landscape of human brain metastases

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.03.455000

N/A

0DataRank · unranked

2 citations

Kimberly Hoang, Edjah K. Nduom, Andreas Wieland, Stewart G. Neill, Matthew Schniederjan +5 more

YAP1 transcription factor expression to define subsets of cancers with T-cell inflamed phenotype in a pan-tumor analysis across 33 tumor types.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2610

N/A

0DataRank · unranked

1 citations

Andrei A. Ivanov, Guojing Zhang, Fadlo R. Khuri, Suresh S. Ramalingam, Haian Fu +3 more

Distinct phenotypic states and spatial distribution of CD8+ T cell clonotypes in human brain metastases

Cell Reports Medicine(2022)10.1016/j.xcrm.2022.100620

N/A

0DataRank · unranked

105 citations

Kimberly Hoang, Edjah K. Nduom, Andreas Wieland, Stewart G. Neill, Matthew Schniederjan +5 more

mTOR regulates T cell exhaustion and PD-1–targeted immunotherapy response during chronic viral infection

Journal of Clinical Investigation(2022)10.1172/jci160025

N/A

0DataRank · unranked

89 citations

Charles M. Perkins, Yamato Sajiki, Chase Chastain, Rajesh M. Valanparambil, Andreas Wieland +7 more

MERTK activation drives osimertinib resistance in EGFR-mutant non–small cell lung cancer

Journal of Clinical Investigation(2022)10.1172/jci150517

N/A

0DataRank · unranked

46 citations

Justus M. Huelse, Dmitri Kireev, Zikang Tan, Luxiao Chen, Subir Goyal +10 more

Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant

Journal of Clinical Oncology(2022)10.1200/jco.21.02986

N/A

0DataRank · unranked

43 citations

Jennifer W. Carlisle, Susanne L. Linderman, Akil Akthar, Ralph Linwood Millett, Lilin Lai +34 more

EGFR-phosphorylated GDH1 harmonizes with RSK2 to drive CREB activation and tumor metastasis in EGFR-activated lung cancer

Cell Reports(2022)10.1016/j.celrep.2022.111827

N/A

0DataRank · unranked

33 citations

Jaemoo Chun, Jung Seok Hwang, Chaoyun Pan, Jie Li, Austin C. Boese +10 more

Spatially variant immune infiltration scoring in human cancer tissues

npj Precision Oncology(2022)10.1038/s41698-022-00305-4

N/A

0DataRank · unranked

39 citations

Thomas Hu, Jeongjin Lee, Jeffrey Aldrich, Sunil Badve, Yesim Gökmen‐Polar +5 more

Bevacizumab’s Association With a Decreased Risk of Brain Metastases in ECOG-ACRIN E1505, a Phase 3 Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab in Surgically Resected NSCLC

JTO Clinical and Research Reports(2022)10.1016/j.jtocrr.2021.100274

N/A

0DataRank · unranked

8 citations

Yating Wang, Zhuoxin Sun, Heather A. Wakelee, Suresh S. Ramalingam, Joan Schiller +1 more

Multiplexed protein profiling reveals spatial subcellular signaling networks

iScience(2022)10.1016/j.isci.2022.104980

N/A

0DataRank · unranked

2 citations

Thomas Hu, Mythreye Venkatesan, Mayar Allam, Frank Schneider, Suresh S. Ramalingam +3 more

Characteristics and anatomic location of PD-1 + TCF1 + stem-like CD8 T cells in chronic viral infection and cancer

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2221985120

N/A

0DataRank · unranked

77 citations

Rebecca C. Obeng, Tahseen H. Nasti, Daniel T. McManus, Alice O. Kamphorst, Sivaram Gunisetty +11 more

Harnessing CD8 T cell responses using PD-1–IL-2 combination therapy

Trends in cancer(2023)10.1016/j.trecan.2023.11.008

N/A

0DataRank · unranked

50 citations

Suresh S. Ramalingam, Rafi Ahmed, Masao Hashimoto

Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1316

N/A

0DataRank · unranked

39 citations

Tahseen H. Nasti, Daniel Y. Chang, Masao Hashimoto, Sakshi Malik, Daniel T. McManus +16 more

Lorlatinib Tolerability and Association With Clinical Outcomes in Patients With Advanced ALK- or ROS1-Rearranged NSCLC: A Brief Report

JTO Clinical and Research Reports(2023)10.1016/j.jtocrr.2023.100546

N/A

0DataRank · unranked

4 citations

Noura J. Choudhury, Fiona Ehrich, Tyler Beardslee, Danielle Brazel, Shannon Zhang +8 more

Natural History and Real-World Treatment Outcomes for Patients With NSCLC Having EGFR Exon 20 Insertion Mutation: An International Association for the Study of Lung Cancer–American Society of Clinical Oncology CancerLinQ Study

JTO Clinical and Research Reports(2023)10.1016/j.jtocrr.2023.100592

N/A

0DataRank · unranked

7 citations

Renjian Jiang, Zhonglu Huang, Becky Bunn, Murry W. Wynes, Jeffrey M. Switchenko +4 more

BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer

npj Vaccines(2023)10.1038/s41541-023-00779-8

N/A

0DataRank · unranked

5 citations

Lilin Lai, Margaret A. Johns, Meredith E. Davis-Gardner, Susanne L. Linderman, Tarrant McPherson +18 more

Safety and efficacy of durvalumab after concurrent chemoradiation in Black patients with locally advanced non–small cell lung cancer

Cancer(2023)10.1002/cncr.34915

N/A

0DataRank · unranked

3 citations

James Janopaul‐Naylor, Hamilton S. McGinnis, Aparna H. Kesarwala, Sibo Tian, William Stokes +8 more

175P Radiomic biomarker of vessel tortuosity for monitoring treatment change: Preliminary findings in prospective evaluation of ECOG-ACRIN EA5163

Annals of Oncology(2023)10.1016/j.annonc.2023.09.2899

N/A

0DataRank · unranked

1 citations

Fenghai Duan, Vidya Sankar Viswanathan, Mohammadhadi Khorrami, Ning An, Vamsidhar Velcheti +7 more

Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesis

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.26.525772

N/A

0DataRank · unranked

1 citations

Chunzi Huang, Austin C. Boese, Yuning Hou, Junghui Koo, Janna K. Mouw +20 more

Live-cell invasive phenotyping uncovers the ALK2/BMP6 iron homeostasis pathway as a therapeutic vulnerability in LKB1-mutant lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.06.14.544941

N/A

0DataRank · unranked

1 citations

Chang-Soo Seong, Rebecca E. Parker, Bhakti Dwivedi, Robert A. Arthur, Ashok Reddy Dinasarapu +9 more

Data from Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib

(2023)10.1158/0008-5472.c.6513256.v1

N/A

0DataRank · unranked

0 citations

Zhen Chen, Hongjing Zang, Songqing Fan, Jiajia Gu, Guojing Zhang +7 more

DNA topoisomerase II inhibition potentiates osimertinib’s therapeutic efficacy in EGFR-mutant non–small cell lung cancer models

Journal of Clinical Investigation(2024)10.1172/jci172716

N/A

0DataRank · unranked

30 citations

Karin A. Vallega, Dongsheng Wang, Zihan Quan, Songqing Fan, Qiming Wang +4 more

Spatially resolved subcellular protein–protein interactomics in drug-perturbed lung-cancer cultures and tissues

Nature Biomedical Engineering(2024)10.1038/s41551-024-01271-x

N/A

0DataRank · unranked

15 citations

Thomas Hu, Abhijeet Venkataraman, Felix G. Rivera Moctezuma, Efe Ozturk, Nicholas Zhang +10 more

Inhibition of hTERT/telomerase/telomere mediates therapeutic efficacy of osimertinib in EGFR mutant lung cancer

The Journal of Experimental Medicine(2024)10.1084/jem.20240435

N/A

0DataRank · unranked

15 citations

Karin A. Vallega, Dongsheng Wang, Zihan Quan, Songqing Fan, Qiming Wang +4 more

Targeting Transient Receptor Potential Melastatin‐2 (TRPM2) Enhances Therapeutic Efficacy of Third Generation EGFR Inhibitors against EGFR Mutant Lung Cancer

Advanced Science(2024)10.1002/advs.202310126

N/A

0DataRank · unranked

10 citations

Karin A. Vallega, Vijay K. Boda, Zihan Quan, Dongsheng Wang, Songqing Fan +5 more

Characterisation of clinical response and transcriptional profiling of proliferating CD8 T cells in the blood of cancer patients after PD-1 monotherapy or combination therapy

BMJ Oncology(2024)10.1136/bmjonc-2024-000328

N/A

0DataRank · unranked

4 citations

Tahseen H. Nasti, Kylee L. Martens, Peng Li, Annapaola Mariniello, Daniel Y. Chang +14 more

Incidence, Correlates, and Prognostic Significance of Mixed Response in Advanced Non-small Cell Lung Cancer

The Oncologist(2024)10.1093/oncolo/oyad335

N/A

0DataRank · unranked

2 citations

Yating Wang, Suresh S. Ramalingam, Sheena Bhalla, Zhuoxin Sun, Hossein Borghaei +3 more

Equipoise Is No Longer a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.08.023

N/A

0DataRank · unranked

2 citations

Rebecca D. Pentz, Suresh S. Ramalingam, Jennifer W. Carlisle

Targeting MKK3/c-Myc interaction to overcome osimertinib acquired resistance in EGFR mutant lung cancer

Cancer Letters(2025)10.1016/j.canlet.2025.218010

N/A

0DataRank · unranked

3 citations

Karin A. Vallega, Dongsheng Wang, Elsa Bildtsen, Haian Fu, Suresh S. Ramalingam +3 more

Biomarker Testing and Patterns of Treatment in Patients with NSCLC: An International Association for The Study of Lung Cancer Analysis of American Society of Clinical Oncology CancerLinQ Discovery Data

JTO Clinical and Research Reports(2025)10.1016/j.jtocrr.2025.100816

N/A

0DataRank · unranked

0 citations

Gregory J. Joseph, Manali Rupji, Zhonglu Huang, Becky Bunn, Murry W. Wynes +7 more

High PER1 expression is associated with STK11 mutation and clinical biomarkers of immunotherapy resistance in lung adenocarcinoma

Journal of Cancer Research and Clinical Oncology(2025)10.1007/s00432-025-06269-9

N/A

0DataRank · unranked

0 citations

Leon McSwain, Wei Zhou, Adam I. Marcus, Haian Fu, Suresh S. Ramalingam +3 more

Exposed phosphatidylserine is a non-classical inhibitory molecule during CD8 T cell exhaustion 2323

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.250

N/A

0DataRank · unranked

0 citations

Ewelina Sobierajska, Minghao Gong, Daniel T. McManus, Maheshwor Thapa, Judong Lee +12 more

YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell–Inflamed Phenotype

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.11.006

N/A

0DataRank · unranked

165 citations

Bhakti Dwivedi, Zhengjia Chen, Chao Zhang, Benjamin G. Barwick, Vinicius Ernani +13 more

Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol

The Lancet Oncology(2020)10.1016/s1470-2045(20)30475-7

N/A

0DataRank · unranked

125 citations

Vassiliki A. Papadimitrakopoulou, Katherine Minichiello, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +21 more

Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti–PD-(L)1 Therapy

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3305

N/A

0DataRank · unranked

125 citations

Pasi A. Jänne, Mateusz Opyrchal, Navid Hafez, Luis E. Raez, Dmitry I. Gabrilovich +15 more

Overcoming acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589)

Cancer(2020)10.1002/cncr.32744

N/A

0DataRank · unranked

48 citations

Guoqing Qian, Dan Zong, Songqing Fan, Taofeek K. Owonikoko, Suresh S. Ramalingam +2 more

A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid Tumors

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2697

N/A

0DataRank · unranked

14 citations

R. Donald Harvey, Bradley Curtis Carthon, Zhengjia Chen, Colleen Lewis, Hanna Collins +16 more

Efficacy and safety of immune checkpoint blockade in self‐identified Black patients with advanced non–small cell lung cancer

Cancer(2020)10.1002/cncr.33141

N/A

0DataRank · unranked

24 citations

Subir Goyal, Zhengjia Chen, Anne Engelhart, Jennifer W. Carlisle, Tyler Beardslee +7 more

ECOG-ACRIN 5162: A phase II study of osimertinib 160 mg in NSCLC with EGFR exon 20 insertions.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9513

N/A

0DataRank · unranked

104 citations

Yating Wang, Lecia V. Sequist, Suresh S. Ramalingam, Zofia Piotrowska

ALCHEMIST: Adjuvant targeted therapy or immunotherapy for high-risk resected NSCLC.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps9077

N/A

0DataRank · unranked

31 citations

Sumithra J. Mandrekar, Geoffrey R. Oxnard, David Kozono, Shauna L. Hillman, Suzanne E. Dahlberg +13 more

Lung-MAP (SWOG S1400): Design, implementation, and lessons learned from a biomarker-driven master protocol (BDMP) for previously-treated squamous lung cancer (sqNSCLC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9576

N/A

0DataRank · unranked

2 citations

Vassiliki A. Papadimitrakopoulou, Katherine Minichiello, David R. Gandara, Fred R. Hirsch, Philip C. Mack +14 more

KRAS G12C mutation associated outcomes among patients with locally advanced non-small cell lung cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e21079

N/A

0DataRank · unranked

2 citations

Madhusmita Behera, Conor Steuer, Suchita Pakkala, Jennifer W. Carlisle, Taofeek K. Owonikoko +7 more

The novel MET inhibitor, HQP8361, possesses single agent activity and enhances therapeutic efficacy of osimertinib, against NSCLC cells with acquired resistance to osimertinib due to MET amplification

Research Square (Research Square)(2020)10.21203/rs.3.rs-25317/v1

N/A

0DataRank · unranked

1 citations

Yiting Li, Kevin D.-Y. Sun, Jiajia Gu, Zhen Chen, Taofeek K Omonikoko +3 more

SWOG S1400F (NCT03373760): A phase II study of durvalumab plus tremelimumab for previously treated patients with acquired resistance to PD-1 checkpoint inhibitor therapy and stage IV squamous cell lung cancer (Lung-MAP Sub-study).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9623

Top 100%

0DataRank

Top 100%0 citations

Mary W. Redman, Naiyer A. Rizvi, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +14 more

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

UNC Libraries(2020)10.17615/74ry-7003

N/A

0DataRank · unranked

0 citations

Editta Baldini, Pierre-Jean Souquet, Grace K. Dy, Ariel López-Chávez, Federico Cappuzzo +25 more

Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib

Cancer Research(2021)10.1158/0008-5472.can-21-0556

N/A

0DataRank · unranked

67 citations

Zhen Chen, Hongjing Zang, Songqing Fan, Jiajia Gu, Guojing Zhang +7 more

Suresh S. Ramalingam

Indexed papers

Top data-sharing exemplar

Papers